Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Cerebral Scanning Technology Detects Brain Pathologies

By HospiMedica International staff writers
Posted on 15 Jan 2018
A portable, non-invasive device detects asymmetry of intracranial fluid volumes in patients undergoing neurological assessment.

The Cerebrotech (Pleasanton, CA, USA) Visor is a novel bioimpedance spectroscopy device that detects changes and distribution of cerebral fluids using volumetric impedance phase-shift spectroscopy (VIPS). More...
The device consists of a headband with multiple integrated antennas that broadcast and receive each other’s signals; the frequency response of the phase angle between a transmitter and receiver antenna represents changes in the electrical properties of tissue as a direct result of small changes in intracranial fluids.

A computer algorithm analyzes the changes in tissue electrical properties, providing a visual readout on a monitor of the detected changes. The ratio of bioimpedance measurements between the brain's right and left hemispheres, and especially changes in that ratio, can help detect any fluid asymmetry during neurologic assessment. Proprietary machine learning algorithms are then used to differentiate between the bioimpedance profiles of various brain pathologies, such as stroke, trauma, swelling, and others. The system has been approved by the U.S. Food and Drug Administration (FDA).

“We understand the challenges facing medical professionals who need to quickly assess patients with neurologic symptoms. The Cerebrotech Visor is designed to be portable, fast, and accurate,” said Mitch Levinson, CEO of Cerebrotech Medical Systems. “Utilizing the vast amount of data captured by our proprietary Cerebrotech Visor, our mission is to develop unique algorithms that can help physicians to better detect and diagnose a wide range of neurological conditions, improving outcomes for patients while reducing overall healthcare costs.”

“A simple, easy-to-use device that can provide accurate information about cerebral fluids in 30 seconds is an important development,” said neurologist Professor Andrei Alexandrov, MD, of the University of Tennessee Center for Health Science (Memphis, USA). “During neurologic assessment, presence and magnitude of fluid asymmetry is a critical piece of information that will help us understand and evaluate our patients. I see tremendous potential for this technology for a large cross-section of patients with neurologic symptoms and various conditions."

Related Links:
Cerebrotech


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Emergency Ventilator
Shangrila935
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.